Vimian Group AB (publ) (OTCMKTS:VIMGF) Sees Large Decrease in Short Interest

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the target of a large drop in short interest during the month of February. As of February 15th, there was short interest totalling 78,500 shares, a drop of 11.5% from the January 31st total of 88,700 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 785.0 days.

Vimian Group AB (publ) Stock Performance

VIMGF stock opened at C$3.50 on Thursday. Vimian Group AB has a 1 year low of C$2.68 and a 1 year high of C$4.12. The stock’s fifty day moving average is C$3.53 and its two-hundred day moving average is C$3.71.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.